Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
By the end of this chapter the reader should know:
Why science and research are relevant to all paediatricians, not just scientists and academics
Why children's biomedical research is essential
The relevance of synthesizing existing evidence and identifying gaps
How children's research has evolved
Why contributing to research to reduce uncertainties in care is a clinical obligation
How to acquire research skills
How and why we should involve patients, parents and the public
The practice of medicine is described as both ‘art and science’, a helpful phrase that emphasizes that the care a doctor provides encompasses subjective (empathy, sensitivity, understanding, communication) and objective (evidence, factual knowledge, competencies) elements working in harmony. We all need to practise the ‘art’ of medicine when we explain science and research concepts to patients.
The very best paediatricians are also able to critically evaluate what they are taught, synthesize existing evidence, challenge dogma, identify knowledge gaps and understand how medicine advances through patient-centred research. We hope that this chapter will enable you to appreciate why these are professional obligations for paediatricians, and central, not peripheral, to clinical practice. We also hope that you will find that applying scientific principles to diagnostic and therapeutic problems is fun and rewarding .
The word science is derived from the Latin word for knowledge, ‘scientia’. Science is systematic; it builds knowledge incrementally through testing hypotheses. Science is perhaps best defined by the acceptance that there are few absolute truths, only ever diminishing uncertainty with each null hypothesis that is rejected following empirical testing. As we progress through our careers, we have a responsibility not only to test new therapies as they become available, but also to help identify which treatments and clinical practices in current use are harmful or useless, and progressively reduce uncertainties in care.
Try and project yourself thirty years into the future; look back at what you are being taught now; much of this will not have withstood the advance of knowledge and scientific scrutiny. If you think this is an exaggerated argument, consider two salutary lessons from the history of paediatrics ( Box 1.1 ). These examples illustrate two key points: that it is dangerous to assume that an untested practice is harmless and that getting evidence adopted into practice can be problematic. Try and think of examples of treatments or practices that are not evidence based but are widely used. Might these practices be harmful? What studies could be done to resolve these uncertainties? Try also to think of examples where translation of evidence into healthcare policy could be expedited through collaborative advocacy by professional bodies, charities and other third sector organizations.
In the early part of the last century, the possibility that an enlarged thymus was implicated in sudden infant death led to the practice of irradiation to reduce thymic size. A quote from that time illustrates that part of the argument in favour of irradiation was that even if not beneficial, it was certainly not harmful and that the procedure would at the very least alleviate parental anxiety: ‘The obstetrician or pediatrician should accede to the wishes of parents who want neonatal X-rays of their children. It might even be wise to administer therapeutic dosage over the thymus; assurance gained by this apparently harmless and perhaps beneficial procedure will aid in alleviating an anxiety which may become a thymus phobia’ (Conti and Patton 1948). The substantially increased risk of cancer following thymic irradiation was subsequently established.
From the 1940s until the 1980s childcare experts recommended the prone sleeping position for infants. This advice was indirectly supported by the decreased work of breathing in the prone position for neonates with respiratory distress. However, prone sleeping had also been noted as a possible risk for sudden infant death syndrome and by the 1970s there was reliable evidence from observational and epidemiological studies, reinforced by the New Zealand Cot Death Study ending in 1990, that this should be avoided. Systematic preventive efforts did not begin until the early 1990s, largely as a result of a campaign led by a charity, the Foundation for the Study of Infant Deaths, together with strong media interest, which led to the Department of Health issuing a policy statement followed by a national campaign, ‘Reduce the risk’. This illustrates the need for clear strategies to avoid delay in translating evidence into practice.
‘Children are not little adults.’
Children's research is necessary because the biology of disease in children is not necessarily the same as in adults. Human physiology alters with age, so that the actions of medicines may differ in the fetus, in children, and in adults (see also Chapter 36, Pharmacology and therapeutics ). There are some important examples of where this is clearly the case. Aspirin is widely used for pain relief and to reduce fever in adults but is not recommended for use in children because of the risk of a serious condition, Reye's syndrome, which causes liver damage and encephalopathy. Young people with cancer have significantly better survival when treated with protocols developed for children compared with protocols used for adults. The use of treatments designed for adults in children without adequate testing is dangerous and new treatments are not necessarily better than old ( Box 1.2 ). Understanding the science of children's disease can also help develop adult treatments ( Box 1.3 ).
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here